Biotherapies are now one of the major drivers of innovation in healthcare. Faced with these challenges, Bourgogne-Franche-Comté is confirming its role as a leading region with the update of its Biotherapies & Bioproduction brochure.
A region dedicated to therapeutic innovation
With its strategic location in the heart of Europe, high-performance infrastructure, and solid industrial base, the region offers project leaders an environment conducive to the development of cutting-edge therapeutic solutions.
Clear and shared ambitions
In line with the France 2030 national plan, the Region has defined an ambitious roadmap for the years 2024-2028. In particular, it aims to:
- Promote the emergence of innovative medicines to contribute to our country’s sovereignty
- Provide healthcare to citizens at acceptable costs, both for patients and for our healthcare system
- Raise its profile and become a hub for investment and projects in biotherapies and bioproduction
A mobilized ecosystem
Research laboratories, university hospitals, centers of excellence, start-ups, and large groups: more than 500 regional players are committed on a daily basis to accelerating innovation and bringing research closer to patients.
Discover the brochure
This new edition brings together all of these assets, key figures, and testimonials to better understand why Bourgogne-Franche-Comté is establishing itself as a key player in the field.